We show that the lymphocyte marker SLAMF6 is unexpectedly aberrantly expressed on primitive AML cells and demonstrate that the SLAMF6 upregulation protects AML cells from T cell-mediated killing. Here, SLAMF6 is linked to acute myeloid leukemia.